Clinical Trial Update: Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder [Phase 4]

View source ↗

Summary

Open-label Phase 4 study evaluating lithium in combination with extended-release carbamazepine for rapid cycling bipolar disorder; the update does not report re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Carbamazepine ER (extended-release) (carbamazepine)
• Lithium (Lithium carbonate)

Snippet

Sponsor: Creighton University | Conditions: Bipolar Disorder | Phase 4 | Status: UNKNOWN